Mini-review: Antimicrobial central venous catheters - recent advances and strategies

Biofouling

Volumn 27, Issue 6, 2011, Pages 609-620

  Sousa, Cláudia ^a   Henriques, Mariana ^a   Oliveira, Rosário ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Antimicrobial; Bacterial adhesion; Biofilm; Catheter related infection; Central venous catheter; Nosocomial infection

Indexed keywords

BACTERIA (MICROORGANISMS);

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; DRUG CARRIER;

BACTERIOPHAGE; BACTERIUM ADHERENCE; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; MICROBIOLOGY; REVIEW;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL ADHESION; BACTERIOPHAGES; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DRUG CARRIERS; HUMANS;

EID: 80053920152     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2011.593261     Document Type: Review

References (109)

1. Alkawash MA, Soothill JS, Schiller NL. 2006. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. APMIS 114:131-138.
2. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. 2007. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 51:1556-1558.
3. Azeredo J, Sutherland IW. 2008. The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9:261-266.
4. Bagheri M, Beyermann M, Dathe M. 2009. Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob Agents Chemother 53:1132-1141.
5. Bailey E, Berry N, Cheesbrough JS. 2002. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 50:615-617.
6. Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M. 2011. Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem 18:256-279.
7. Baveja JK, Willcox MD, Hume EB, Kumar N, Odell R, Poole-Warren LA. 2004. Furanones as potential antibacterial coatings on biomaterials. Biomaterials 25:5003-5012.
8. Ben-Ami R, Weinberger M, Orni-Wasserlauff R, Schwartz D, Itzhaki A, Lazarovitch T, Bash E, Aharoni Y, Moroz I, Giladi M. 2008. Time to blood culture positivity as a marker for catheter-related candidemia. J Clin Microbiol 46:2222-2226.
9. Berrington A, Gould FK. 2001. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 48:597-603.
10. Bookstaver PB, Williamson JC, Tucker BK, Raad I, Sherertz RJ. 2009. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother 43:210-219.
11. Bower CK, Parker JE, Higgins AZ, Oest ME, Wilson JT, Valentine BA, Bothwell MK, McGuire J. 2002. Protein antimicrobial barriers to bacterial adhesion: in vitro and in vivo evaluation of nisin-treated implantable materials. Colloids Surf B-Biointerfaces 25:81-90.
12. Buckler BS, Sams RN, Goei VL, Krishnan KR, Bemis MJ, Parker DP, Murray DL. 2008. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr Infect Dis J 27:762-764.
13. Camargo LF, Marra AR, Büchele GL, Sogayar AM, Cal RG, de Sousa JM, Silva E, Knobel E, Edmond MB. 2009. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study. J Hosp Infect 72:227-233.
14. Carmen JC, Roeder BL, Nelson JL, Ogilvie RL, Robison RA, Schaalje GB, Pitt WG. 2005. Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am J Infect Control 33:78-82.
15. Casey AL, Mermel LA, Nightingale P, Elliott TS. 2008. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 8:763-776.
16. Cateau E, Rodier MH, Imbert C. 2008. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J Antimicrob Chemother 62:153-155.
17. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. 2002. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136:792-801.
18. Chen H, Zhang Z, Chen Y, Brook MA, Sheardown H. 2005. Protein repellant silicone surfaces by covalent immobilization of poly(ethylene oxide). Biomaterials 26:2391-2399.
19. Cirioni O, Giacometti A, Ghiselli R, Bergnach C, Orlando F, Mocchegiani F, Silvestri C, Licci A, Skerlavaj B, Zanetti M, et al. 2006. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides 27:2104-2110.
20. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
21. Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE. 1994. Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob Agents Chemother 38:2803-2809.
22. Crisante F, Francolini I, Bellusci M, Martinelli A, D’Ilario L, Piozzi A. 2009. Antibiotic delivery polyurethanes containing albumin and polyallylamine nanoparticles. Eur J Pharm Sci 36:555-564.
23. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. 2003. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47:3145-3148.
24. Curtin JJ, Donlan RM. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50:1268-1275.
25. Darouiche RO, Raad I, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, et al. 1999. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 340:1-8.
26. Davey ME, O’Toole G. 2000. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64:847-867.
27. Decraene V, Pratten J, Wilson M. 2006. Cellulose acetate containing toluidine blue and rose Bengal is an effective antimicrobial coating when exposed to white light. Appl Environ Microbiol 72:4436-4439.
28. Del Pozo JL, Rouse MS, Mandrekar JN, Steckelberg JM, Patel R. 2009a. The electricidal effect: reduction of Staphylococcus and Pseudomonas biofilms by prolonged exposure to low-intensity electrical current. Antimicrob Agents Chemother 53:41-45.
29. Del Pozo JL, Rouse MS, Mandrekar JN, Sampedro MF, Steckelberg JM, Patel R. 2009b. Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 53:35-40.
30. Del Pozo JL, Rouse MS, Euba G, Kang CI, Mandrekar JN, Steckelberg JM, Patel R. 2009c. The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis. Antimicrob Agents Chemother 53:4064-4068.
31. Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB. 2007. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51:2733-2740.
32. Donlan RM. 2008. Biofilms on central venous catheters: is eradication possible? Curr Top Microbiol Immunol 322:133-161.
33. Donlan RM. 2009. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17:66-72.
34. Doolittle MM, Cooney JJ, Caldwell DE. 1996. Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol 16:331-341.
35. Elliott TS. 2007. An update on antimicrobial central venous catheters. J Hosp Infect 65(Suppl 2):34-38.
36. Engelsman AF, Krom BP, Busscher HJ, van Dam GM, Ploeg RJ, van der Mei HC. 2009. Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model. Acta Biomater 5:1905-1910.
37. Etienne O, Picart C, Taddei C, Haikel Y, Dimarcq JL, Schaaf P, Voegel JC, Ogier JA, Egles C. 2004. Multilayer polyelectrolyte films functionalized by insertion of defensin: a new approach to protection of implants from bacterial colonization. Antimicrob Agents Chemother 48:3662-3669.
38. Fang FC. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99:2818-2825.
39. Finelli A, Burrows LL, DiCosmo FA, DiTizio V, Sinnadurai S, Oreopoulos DG, Khoury AE. 2002. Colonization-resistant antimicrobial-coated peritoneal dialysis catheters: evaluation in a newly developed rat model of persistent Pseudomonas aeruginosa peritonitis. Perit Dial Int 22:27-31.
40. Frasca D, Dahyot-Fizelier C, Mimo O. 2010. Prevention of central venous catheter-related infection in the intensive care unit. Crit Care 14:212-219.
41. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54:397-404.
42. 4@Ag nanoparticles. Nanotechnology 18:604-611.
43. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Tera´n LM. 2010. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 135:1-11.
44. Guedon C, Nouvellon M, LaLaude O, Lerebours E. 2002. Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. J Parenter Enter Nutr 26:109-113.
45. Guggenbichler JP, Böswald M, Lugauer S, Krall T. 1999. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 27(Suppl):S16-S23.
46. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. 2009. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care 13:R35.
47. Halwani M, Yebio B, Suntres ZE, Alipour M, Azghani AO, Omri A. 2008. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa. J Antimicrob Chemother 62:1291-1297.
48. Hamill P, Brown K, Jenssen H, Hancock REW. 2008. Novel anti-infectives: is host defence the answer? Curr Opin Biotechnol 6:628-636.
49. Hancock REW. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1:156-164.
50. Hancock REW, Sahl H-G. 2006. Antimicrobial and hostdefense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557.
51. Hazan Z, Zumeris J, Jacob H, Raskin H, Kratysh G, Vishnia M, Dror N, Barliya T, Mandel M, Lavie G. 2006. Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves. Antimicrob Agents Chemother 50:4144-4152.
52. Hetrick EM, Schoenfisch MH. 2007. Antibacterial nitric oxide releasing xerogels: cell viability and parallel plate flow cell adhesion studies. Biomaterials 28:1948-1956.
53. Hilpert K, Elliott M, Jenssen H, Kindrachuk J, Fjell CD, Körner J, Winkler DF, Weaver LL, Henklein P, Ulrich AS, et al. 2009. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol 16:58-69.
54. Hsu SH, Tseng HJ, Lin YC. 2010. The biocompatibility and antibacterial properties of waterborne polyurethane- silver nanocomposites. Biomaterials 31:6796-6808.
55. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328-346.
56. Kaplan JB, Ragunath C, Velliyagounder K, Fine DH, Ramasubbu N. 2004. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 48:2633-2636.
57. Knetsch MLW, Koole LH. 2011. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers 3:340-366.
58. Ko KS, Lee JY, Song JH, Peck KR. 2010. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. J Korean Med Sci 25:1722-1726.
59. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Baker J, Allon M. 2002. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 61:1136-1142.
60. Lazzell AL, Chaturvedi AK, Pierce CG, Prasad D, Uppuluri P, Lopez-Ribot JL. 2009. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 64:567-570.
61. Logghe C, Van Ossel C, D’Hoore W, Ezzedine H, Wauters G, Haxhe JJ. 1997. Evaluation of chlorexidine and silver sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemia patients: a randomized controlled trial. J Hosp Infect 37:145-156.
62. Lönn-Stensrud J, Landin MA, Benneche T, Petersen FC, Scheie AA. 2009. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections? J Antimicrob Chemother 63:309-316.
63. Maki DG, Stolz SM, Wheeler S, Mermel LA. 1997. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127:257-266.
64. Manefield M, Rasmussen TB, Henzter M, Andersen JB, Steinberg P, Kjelleberg S, Givskov M. 2002. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Microbiology 148:1119-1127.
65. Mansouri MD, Darouiche RO. 2007. In vitro antimicrobial activity of N-acetylcysteine against bacteria colonizing central venous catheters. Int J Antimicrob Agents 29:471-483.
66. Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM. 2003. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents 22(Suppl 2):95-100.
67. Marik PE, Abraham G, Careau P, Varon J, Fromm Jr RE. 1999. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 27:1128-1131.
68. Martinelli A, D’Ilario L, Francolini I, Piozzi A. 2011. Water state effect on drug release from an antibiotic loaded polyurethane matrix containing albumin nanoparticles. Int J Pharm 407:197-206.
69. McGee DC, Gould MK. 2003. Preventing complications of central venous catheterization. N Engl J Med 348:1123-1133.
70. McMullin BB, Chittock DR, Roscoe DL, Garcha H, Wang L, Miller CC. 2005. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit. Respir Care 50:1451-1456.
71. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad I, Rijnders BJ, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1-45.
72. Nadell CD, Xavier JB, Foster KR. 2009. The sociobiology of biofilms. FEMS Microbiol Rev 33:206-224.
73. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, et al. 2002. Guidelines for the prevention of intravascular catheter-related infections. Center for Disease Control and Prevention. MMWR Recomm Rep 51:1-29.
74. Olofsson AC, Hermansson M, Elwing H. 2003. N-acetyl-Lcysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol 69:4814-4822.
75. Page K, Wilson M, Parkin IP. 2009. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 19:3819-3831.
76. Perni S, Prokopovich P, Piccirillo C, Pratten J, Parkin IP, Wilson M. 2009. Toluidine blue-containing polymers exhibit potent bactericidal activity when irradiated with red laser light. J Mater Chem 19:2715-2723.
77. Perni S, Piccirillo C, Kafizas A, Uppal M, Pratten J, Wilson M, Parkin IP. 2010. Antibacterial activity of light-activated silicone containing methylene blue and gold nanoparticles of different sizes. J Clust Sci 21:427-438.
78. Perron GG, Zasloff M, Bell G. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273:251-256.
79. Piper C, Draper LA, Cotter PD, Ross RP, Hill C. 2009. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother 64:546-551.
80. Qian Z, Sagers RD, Pitt WG. 1994. The effect of ultrasonic frequency upon enhanced killing of Pseudomonas aeuruginosa biofilm. Ann Biomed Eng 25:69-76.
81. Raad I, Hanna HA. 2002. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 162:871-878.
82. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. 2008a. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother 62:746-750.
83. Raad I, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. 2008b. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21:385-392.
84. Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, Cook G, Costerton W. 2003. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47:3580-3585.
85. Rai M, Yadav A, Gade A. 2009. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76-83.
86. Rasmussen TB, Bjarnsholt T, Skindersoe ME, Hentzer M, Kristoffersen P, Köte M, Nielsen J, Eberl L, Givskov M. 2005. Screening for quorum-sensing inhibitors (QSI) by use of a novel genetic system, the QSI selector. J Bacteriol 187:1799-1814.
87. Rediske AM, Roeder BL, Nelson JL, Robison RL, Schaalje GB, Robison RA, Pitt WG. 2000. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 44:771-772.
88. Regev-Shoshani G, Ko M, Miller Chris, Av-Gay Y. 2010. Slow release of nitric oxide from charged catheters and its effect on biofilm formation by Escherichia coli. Antimicrob Agents Chemother 54:273-279.
89. Ren D, Bedzyk LA, Ye RW, Thomas SM, Wood TK. 2004. Differential gene expression shows natural brominated furanones interfere with the autoinducer-2 bacterial signalling system of Escherichia coli. Biotechnol Bioeng 88:630-642.
90. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. 2008. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 61:869-876.
91. Ruggeri V, Francolini I, Donelli G, Piozzi A. 2007. Synthesis, characterization, and in vitro activity of antibiotic releasing polyurethanes to prevent bacterial resistance. J Biomed Mater Res A 81:287-298.
92. Rupp ME, Lisco SJ, Lipsett PA, Perl TM, Keating K, Civetta JM, Mermel LA, Lee D, Dellinger EP, Donahoe M, et al. 2005. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143:570-580.
93. Samuel U, Guggenbichler JP. 2004. Prevention of catheterrelated infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 23:75-78.
94. Şanlı O, Biçer E, Işıklan N. 2008. In vitro release study of diltiazem hydrochloride from poly(vinyl pyrrolidone)/ sodium alginate blend microspheres. JAPS 107:1973-1980.
95. Sekhar S, Ohri M, Chakraborti A. 2010. Biofilms: an evolving and universal evasive strategy of bacterial pathogens. In: Mendez-Vilas A, editor. Current research, technology and education topics in applied microbiology and microbial biotechnology. Microbiology book series 2. Badajoz (Spain): Formatex. p. 855-859.
96. Shah CB, Mittelman MW, Costerton JW, Parenteau S, Pelak M, Arsenault R, Mermel LA. 2002. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46:1674-1679.
97. Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D. 2007. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18:225103-225112.
98. Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK. 2009. Microbial inactivation properties of a new antimicrobial/ antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrol Dial Transplant 24:1937-1945.
99. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
100. Subczynski WK, Wisniewska A. 2000. Physical properties of lipid bilayer membranes: relevance to membrane biological functions. Acta Biochim Pol 47:613-625.
101. Tamilvanan S, Venkateshan N, Ludwig A. 2008. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on devicerelated nosocomial infections. J Control Release 128:2-22.
102. Tebbs SE, Sawyer A, Elliott TS. 1994. Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth 72:587-591.
103. Trautner BW, Darouiche RO. 2004. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med 164:842-850.
104. Varshosaz J. 2007. Insulin delivery systems for controlling diabetes. Recent Pat Endocr Metab Immune Drug Discovery. 1:25-40.
105. Veenstra DL, Saint S, Saha S, Lumeley T, Sullivan SD. 1999. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter related bloodstream infection: a meta-analysis. JAMA 281:261-267.
106. Verma V, Harjai K, Chhibber S. 2010. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling 26:729-737.
107. von Eiff C, Jansen B, Kohnen W, Becker K. 2005. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 65:179-214.
108. Wilson M. 2003. Light-activated antimicrobial coating for the continuous disinfection of surfaces. Infect Control Hosp Epidemiol 24:782-784.
109. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55.